{"title": "Aproximaciones complementarias y alternativas al cuidado de la salud en el Instituto Nacional de Cancerolog\u00eda: estudio de prevalencia", "author": "Ricardo S\u00e1nchez; Marco Venegas", "url": null, "hostname": null, "description": "Objective: To determine use prevalence for alternative and complementary medicines at the National Cancer Institute of Colombia. Methods: A cross-sectional study was carried out. Focus groups were used for designing the survey. Results: 359 surveys were carried out corresponding to patients with different types of cancer. In total 38 types of complementary medicines were reported and the median number of therapies per patient was 2. Some 73.5% (95%CI 68.7%-78.0%) used complementary and alternative therapies, being the group of herbal medicine the most commonly used. Doctors recommended their use in 8% of cases. The family and nearby persons were the main source for accessing this type of therapies. Conclusions: There is a high-frequency utilization of complementary and alternative therapies. The group of herbal medicine is the most common. The findings contradict the lack of access to this type of therapies with in the health system. In our country, additional research is needed in this area.", "sitename": "Revista Colombiana de Cancerolog\u00eda", "date": "2010-09-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Aproximaciones complementarias y alternativas al cuidado de la salud en el Instituto Nacional de Cancerolog\u00eda: estudio de prevalencia\nPalabras clave:Terapias complementarias, neoplasia, estudios transversales, prevalencia.\nResumen\nObjetivo: Determinar la prevalencia de uso de medicinas alternativas y complementarias en los pacientes oncol\u00f3gicos del Instituto Nacional de Cancerolog\u00eda (INC) de Colombia.\nM\u00e9todos: Estudio transversal con un componente cualitativo (grupos focales), a partir del cual se dise\u00f1\u00f3 una encuesta para caracterizar y determinar la frecuencia del uso de terapias alternativas en pacientes del INC.\nResultados: Se aplicaron 359 encuestas en pacientes con distintos tipos de c\u00e1nceres (ginecol\u00f3gicos, de mama, de piel, de cabeza y cuello, del sistema osteomuscular y gastrointestinales). Se reportaron 38 intervenciones diferentes. La mediana de tratamientos utilizados por paciente fue de 2. El 73,5% de los entrevistados (264 pacientes, IC95%: 68,7%-78%) usaron m\u00e9todos terap\u00e9uticos de medicina complementaria y alternativa; especialmente, del grupo de terapias herbales. La principal fuente de acceso a estas terapias fue a trav\u00e9s de familiares o conocidos (68%). Los m\u00e9dicos s\u00f3lo recomendaron su uso en 8% de los pacientes encuestados.\nConclusiones: Se encontr\u00f3 una reiterada utilizaci\u00f3n de terapias complementarias y alternativas; el grupo de terapias herbales basadas en plantas fue el m\u00e1s reportado en dicho grupo de pacientes. El acceso a \u00e9stas no se hace a trav\u00e9s de los sistemas de salud oficiales. En nuestro pa\u00eds se requiere mayor investigaci\u00f3n en el \u00e1rea.\nReferencias bibliogr\u00e1ficas\nNational Center for Complementary and Alternative Medicine. What is Complementary and Alternative Medicine? [internet]. 14 oct. 2009 [citado: 25 feb. 2010]. Disponible en:\n[http://www.nccam.nih.gov/health/whatiscam/](http://www.nccam.nih.gov/health/whatiscam/).\nEisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328(4):246-52.\n[https://doi.org/10.1056/NEJM199301283280406](https://doi.org/10.1056/NEJM199301283280406)\nMedline Plus. Complementary and alternative medicine. [internet]. 19 feb 2010, [citado: 25 feb. 2010]. Disponible en:\n[http://www.nlm.nih.gov/medlineplus/complementaryandalternativemedicine.html](http://www.nlm.nih.gov/medlineplus/complementaryandalternativemedicine.html)\nCassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist. 2004;9(1):80-9.\n[https://doi.org/10.1634/theoncologist.9-1-80](https://doi.org/10.1634/theoncologist.9-1-80)\nEisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the Unites States, 1990-1997: results of a follow-up national survey. JAMA. 1988;280(18):1569-75.\n[https://doi.org/10.1001/jama.280.18.1569](https://doi.org/10.1001/jama.280.18.1569)\nNi H, Simile C, Hardy AM. Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey. Med Care. 2002;40(4):353-8.\n[https://doi.org/10.1097/00005650-200204000-00011](https://doi.org/10.1097/00005650-200204000-00011)\nDevine P. Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer. 2000;88(3):615-9.\n[https://doi.org/10.1002/(SICI)1097-0142(20000201)88:3](https://doi.org/10.1002/(SICI)1097-0142(20000201)88:3)<615::AID-CNCR18>3.0.CO;2-P\nMyers C, Stuber ML, Bonamer-Rheingans JI, Zeltzer LK. Complementary therapies and childhood cancer. Cancer Control. 2005;12(3):172-80.\n[https://doi.org/10.1177/107327480501200305](https://doi.org/10.1177/107327480501200305)\nThe University of Texas. M. D. Anderson Cancer Center. Complementary/integrative therapies. [internet]. 2007 (citado: 27 dic. 2009). Disponible en:\n[http://www.mdanderson.org/departments/cimer/dindex.cfm?pn=5ac57a83-0f8d-4a3f-b743a0cdf23f193c](http://www.mdanderson.org/departments/cimer/dindex.cfm?pn=5ac57a83-0f8d-4a3f-b743a0cdf23f193c).\nSueco Tiban\u00e1 E, Taschner Goldenstein P, de Melo Ribeiro L, Lewin F, Valesin Filho \u00c9S, Prado Soares H, et al. Praying correlates with higher quality of life: results from a survey on complementary/alternative medicine use among a group of Brazilian cancer patients. Sao Paulo Med J. 2004;122(2):60-3.\n[https://doi.org/10.1590/S1516-31802004000200005](https://doi.org/10.1590/S1516-31802004000200005)\nPenson RT, Partridge RA, Rudd P, Seiden MV, Nelson JE, Chabner BA, et al. Laughter: the best medicine? Oncologist. 2005;10(8):651-60.\n[https://doi.org/10.1634/theoncologist.10-8-651](https://doi.org/10.1634/theoncologist.10-8-651)\nUniversity of California Medical Center. National Center for Complementary and Alternative Medicine. Classification of Alternative Therapies. [internet]. 19 feb. 2010 [citado: 25 feb. 2010]. Disponible en:\n[http://cancer.ucsd.edu/Outreach/PublicEducation/CAMs/appendixa.asp](http://cancer.ucsd.edu/Outreach/PublicEducation/CAMs/appendixa.asp).\nNIH Consensus Conference. Acupuncture. JAMA. 1998;280(17):1518-24.\n[https://doi.org/10.1001/jama.280.17.1518](https://doi.org/10.1001/jama.280.17.1518)\nElias MC, Alves E. [Non-conventional medicine: prevalence in oncologic patients]. Rev Bras Cancerol. 2002;48(4):523- 32. Portuguese.\nRichardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505-14.\n[https://doi.org/10.1200/JCO.2000.18.13.2505](https://doi.org/10.1200/JCO.2000.18.13.2505)\nCassileth BR. Complementary therapies: the American experience. Support Care Cancer. 2000;8(1):16-23.\n[https://doi.org/10.1007/s005209900036](https://doi.org/10.1007/s005209900036)\nSagar SM. Acupuncture as an evidence-based option for symptom control in cancer patients. Curr Treat Options Oncol. 2008;9(2-3):117-26.\n[https://doi.org/10.1007/s11864-008-0063-3](https://doi.org/10.1007/s11864-008-0063-3)\nNaeim A, Dy SM, Lorenz KA, Sanati H, Walling A, Asch SM. Evidence-based recommendations for cancer nausea and vomiting. J Clin Oncol. 2008;26(23):3903-10. Review.\n[https://doi.org/10.1200/JCO.2007.15.9533](https://doi.org/10.1200/JCO.2007.15.9533)\nChiu J, Yau T, Epstein RJ. Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers. Support Care Cancer. 2009;17(3):231-40.\n[https://doi.org/10.1007/s00520-008-0526-x](https://doi.org/10.1007/s00520-008-0526-x)\nMcCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer. 2004;12(6):454-62.\n[https://doi.org/10.1007/s00520-004-0598-1](https://doi.org/10.1007/s00520-004-0598-1)\nMathijssen RH, Verweij J, de Bruijn P, Loos WJ, Spareboom A. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst. 2002;94(16):1247-9.\n[https://doi.org/10.1093/jnci/94.16.1247](https://doi.org/10.1093/jnci/94.16.1247)\nD'Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin. 2005;55(5):319-21.\n[https://doi.org/10.3322/canjclin.55.5.319](https://doi.org/10.3322/canjclin.55.5.319)\nBourgeault IL. Physicians' attitudes toward patients' use of alternative cancer therapies. CMAJ. 1996;155(12):1679- 85.\nUkiya M, Akihisa T, Yasukawa K, Tokuda H, Suzuki T, Kimura Y. Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers. J Nat Prod. 2006;69(12):1692-6.\n[https://doi.org/10.1021/np068016b](https://doi.org/10.1021/np068016b)\nUlbricht C, Armstrong J, Basch E, Basch S, Bent S, Dacey C, et al. An evidence-based systematic review of Aloe vera by the natural standard research collaboration. J Herb Pharmacother. 2007;7(3-4):279-323.\n[https://doi.org/10.1080/15228940802153339](https://doi.org/10.1080/15228940802153339)\nFurusawa E, Hirazumi A, Story S, Jensen J. Antitumour potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) on sarcoma 180 ascites tumour in mice. Phytother Res. 2003;17(10):1158-64.\n[https://doi.org/10.1002/ptr.1307](https://doi.org/10.1002/ptr.1307)\nLiu G, Bode A, Ma WY, Sang S, Ho CT, Dong Z. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res. 2001;61(15):5749-56.\nPilarski R, Poczekaj-Kostrzewska M, Ciesio\u0142ka D, Szyfter K, Gulewicz K. Antiproliferative activity of various Uncaria tomentosa preparations on HL-60 promyelocytic leukemia cells. Pharmacol Rep. 2007;59(5):565-72.\nStyczynski J, Wysocki M. Alternative medicine remedies might stimulate viability of leukemic cells. Pediatr Blood Cancer. 2006;46(1):94-8.\n[https://doi.org/10.1002/pbc.20513](https://doi.org/10.1002/pbc.20513)\nVickers AJ. How to design a phase I trial of an anticancer botanical. J Soc Integr Oncol. 2006;4(1):46-51.\nChung VQ, Tattersall M, Cheung HT. Interactions of a herbal combination that inhibits growth of prostate cancer cells. Cancer Chemother Pharmacol. 2004;53(5):384-90.\nC\u00f3mo citar\nDescargas\nDescargas\nPublicado\nN\u00famero\nSecci\u00f3n\nLicencia\nTodos los derechos reservados.", "language": null, "image": null, "pagetype": null, "links": ["#pkp_content_main", "#siteNav", "#pkp_content_footer", "\t\t\t\t\t\thttps://www.revistacancercol.org/index.php/cancer/index\n\t\t\t\t\t", null, "https://www.revistacancercol.org/index.php/cancer/issue/current", "https://www.revistacancercol.org/index.php/cancer/anticipada", "https://www.revistacancercol.org/index.php/cancer/issue/archive", "https://www.revistacancercol.org/index.php/cancer/about/submissions", "https://www.revistacancercol.org/index.php/cancer/indicaciones", "https://www.revistacancercol.org/index.php/cancer/tutoriales", "https://www.revistacancercol.org/index.php/cancer/about/submissions", "https://www.revistacancercol.org/index.php/cancer/formatos", "https://www.revistacancercol.org/index.php/cancer/about", "https://www.revistacancercol.org/index.php/cancer/about", "https://www.revistacancercol.org/index.php/cancer/about/editorialTeam", "https://www.revistacancercol.org/index.php/cancer/etica", "https://www.revistacancercol.org/index.php/cancer/pares", "https://www.revistacancercol.org/index.php/cancer/about/privacy", "https://www.revistacancercol.org/index.php/cancer/about/contact", "https://www.revistacancercol.org/index.php/cancer/estadisticas", "https://www.revistacancercol.org/index.php/cancer/redes", "https://www.revistacancercol.org/index.php/cancer/indizacion", "https://www.revistacancercol.org/index.php/cancer/search", "https://www.revistacancercol.org/index.php/cancer/user/setLocale/es_ES?source=%2Findex.php%2Fcancer%2Farticle%2Fview%2F457", "https://www.revistacancercol.org/index.php/cancer/user/setLocale/en_US?source=%2Findex.php%2Fcancer%2Farticle%2Fview%2F457", "https://doi.org/10.35509/issn.0123-9015", "https://www.revistacancercol.org/index.php/cancer", "https://www.revistacancercol.org/index.php/cancer/user/register", "https://www.revistacancercol.org/index.php/cancer/login", null, "https://www.revistacancercol.org/index.php/cancer/index", "https://www.revistacancercol.org/index.php/cancer/issue/archive", "https://www.revistacancercol.org/index.php/cancer/issue/view/40", "#abstract", "#author_bios", "#references", "#citation", "http://www.nccam.nih.gov/health/whatiscam/", "https://doi.org/10.1056/NEJM199301283280406", "http://www.nlm.nih.gov/medlineplus/complementaryandalternativemedicine.html", "https://doi.org/10.1634/theoncologist.9-1-80", "https://doi.org/10.1001/jama.280.18.1569", "https://doi.org/10.1097/00005650-200204000-00011", "https://doi.org/10.1002/(SICI)1097-0142(20000201)88:3", "https://doi.org/10.1177/107327480501200305", "http://www.mdanderson.org/departments/cimer/dindex.cfm?pn=5ac57a83-0f8d-4a3f-b743a0cdf23f193c", "https://doi.org/10.1590/S1516-31802004000200005", "https://doi.org/10.1634/theoncologist.10-8-651", "http://cancer.ucsd.edu/Outreach/PublicEducation/CAMs/appendixa.asp", "https://doi.org/10.1001/jama.280.17.1518", "https://doi.org/10.1200/JCO.2000.18.13.2505", "https://doi.org/10.1007/s005209900036", "https://doi.org/10.1007/s11864-008-0063-3", "https://doi.org/10.1200/JCO.2007.15.9533", "https://doi.org/10.1007/s00520-008-0526-x", "https://doi.org/10.1007/s00520-004-0598-1", "https://doi.org/10.1093/jnci/94.16.1247", "https://doi.org/10.3322/canjclin.55.5.319", "https://doi.org/10.1021/np068016b", "https://doi.org/10.1080/15228940802153339", "https://doi.org/10.1002/ptr.1307", "https://doi.org/10.1002/pbc.20513", "https://doi.org/10.1007/s00280-003-0746-1", "https://www.revistacancercol.org/index.php/cancer/citationstylelanguage/get/acm-sig-proceedings?submissionId=457&publicationId=399", "https://www.revistacancercol.org/index.php/cancer/citationstylelanguage/get/acs-nano?submissionId=457&publicationId=399", "https://www.revistacancercol.org/index.php/cancer/citationstylelanguage/download/ris?submissionId=457&publicationId=399", "https://www.revistacancercol.org/index.php/cancer/citationstylelanguage/download/bibtex?submissionId=457&publicationId=399", "https://www.revistacancercol.org/index.php/cancer/issue/view/40", "https://www.revistacancercol.org/index.php/cancer/article/view/457/309", "https://www.revistacancercol.org/index.php/cancer/issue/view/40", null, null, null, null, null, null, null, "https://www.revistacancercol.org/index.php/cancer/about/aboutThisPublishingSystem"]}